Balance Sheet

v3.25.0.1

Condensed Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents	$ 14,998,467	$ 3,094,200
Grant receivable	30,756
Prepaid expenses	366,266	413,790
Total current assets	15,395,489	3,507,990
Other assets:
Loan commitment fees	445,731	565,124
Total assets	15,841,220	4,073,114
Current liabilities:
Accounts payable	319,515	156,426
Accrued expenses	559,284	104,157
Total liabilities	878,799	260,583
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,000,000 shares authorized, no shares issued or outstanding at December 31, 2024 and June 30, 2024
Common stock, $0.001 par value; 50,000,000 authorized at December 31, 2024 and June 30, 2024; 41,084,731 and 25,933,217 shares issued and outstanding at December 31, 2024 and June 30, 2024, respectively	41,086	25,934
Additional paid-in capital	84,988,845	69,190,341
Accumulated deficit	(70,067,510)	(65,403,744)
Total stockholders’ equity	14,962,421	3,812,531
Total liabilities and stockholders’ equity	$ 15,841,220	$ 4,073,114

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source